|
|
|
Volumn 13, Issue 1, 2000, Pages 51-56
|
|
Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
ANTIOXIDANT;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
ESTROGEN;
INDAN DERIVATIVE;
NONSTEROID ANTIINFLAMMATORY AGENT;
NOOTROPIC AGENT;
PIPERIDINE DERIVATIVE;
PSYCHOTROPIC AGENT;
SELEGILINE;
TACRINE;
ALGORITHM;
ALZHEIMER DISEASE;
ARTICLE;
CAREGIVER;
CLINICAL TRIAL;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
DRUG INTERACTION;
ECONOMICS;
FEMALE;
GINKGO BILOBA;
HEALTH CARE QUALITY;
HEALTH INSURANCE;
HUMAN;
MALE;
MEDICINAL PLANT;
PATIENT SELECTION;
PHYTOTHERAPY;
PRACTICE GUIDELINE;
PSYCHOLOGICAL ASPECT;
TIME;
ALGORITHMS;
ALZHEIMER DISEASE;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIOXIDANTS;
CAREGIVERS;
CHOLINESTERASE INHIBITORS;
CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
DRUG INTERACTIONS;
ESTROGENS;
FEMALE;
GINKGO BILOBA;
HUMANS;
INDANS;
MALE;
MANAGED CARE PROGRAMS;
NOOTROPIC AGENTS;
PATIENT SELECTION;
PHYTOTHERAPY;
PIPERIDINES;
PLANTS, MEDICINAL;
PSYCHOTROPIC DRUGS;
QUALITY OF HEALTH CARE;
SELEGILINE;
TACRINE;
TIME FACTORS;
VITAMIN E;
|
|
EID: 0033632077
PISSN: 10965645
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (24)
|
|
References (0)
|
